The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Will The Market Size Of The Preimplantation Genetic Testing Market Progress Through 2030?
The preimplantation genetic testing market size has experienced rapid expansion in recent years. It is projected to increase from $0.92 billion in 2025 to $1.03 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.4%. This historical growth can be attributed to several factors including the rising utilization of assisted reproductive technologies, advancements in embryo biopsy techniques, increasing awareness of genetic disease prevention, the expansion of fertility clinics, and improving IVF success outcomes.
The preimplantation genetic testing market is projected to experience substantial expansion in the coming years, reaching a size of $1.57 billion by 2030, propelled by a compound annual growth rate (CAGR) of 11.1%. This anticipated growth during the forecast period is primarily driven by factors such as a heightened need for customized reproductive medicine, the growing integration of sophisticated genomic technologies, the broadening of fertility preservation options, increasing financial commitments to reproductive health infrastructure, and a greater willingness from regulators to approve genetic screening. Key developments expected during this period involve the wider implementation of embryo screening, a surge in the application of next-generation sequencing within IVF, the broadening scope of genetic testing in fertility therapies, a greater desire for better implantation success rates, and a sharpened emphasis on minimizing genetic disorders.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20596&type=smp
Which Major Factors Are Contributing To The Development Of The Preimplantation Genetic Testing Market?
The preimplantation genetic testing market is anticipated to expand due to the growing number of in vitro fertilization (IVF) procedures. IVF involves the external fertilization of an egg by sperm to create an embryo, which is then implanted into the uterus. The increase in IVF procedures is driven by improvements in reproductive technology, rising infertility rates, and heightened public awareness, thereby boosting the preimplantation genetic testing market by increasing the demand for genetic screening of embryos before implantation. For instance, in June 2025, the Human Fertilisation & Embryology Authority, a UK-based independent regulator of fertility treatment, reported that in 2023, 52,400 patients had over 77,500 in vitro fertilization (IVF) cycles at licensed fertility clinics in the UK. Egg freezing cycles further increased from 4,700 in 2022 to 6,900 in 2023, accounting for 7% of all cycles. Consequently, the rising volume of in vitro fertilization (IVF) procedures is a significant driver for the preimplantation genetic testing market.
What Key Segment Areas Are Included In The Preimplantation Genetic Testing Market Assessment?
The preimplantation genetic testing market covered in this report is segmented –
1) By Procedure: Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis
2) By Product: Reagents And Consumables, Instruments, Software
3) By Technology: Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In Situ Hybridization (FISH), Other Technologies
4) By Application: Chromosomal Abnormalities, Aneuploidy Screening, X-Linked Diseases, Embryo Testing, Human Leukocyte Antigen (HLA) Typing, Other Applications
5) By End User: Hospitals, Fertility Centers, Diagnostic Centers, Research Centers And Academic Labs
Subsegments:
1) By Preimplantation Genetic Screening (PGS): Array Comparative Genomic Hybridization (aCGH), Next-Generation Sequencing (NGS), Fluorescence In Situ Hybridization (FISH)
2) By Preimplantation Genetic Diagnosis (PGD): Monogenic Disorders Testing, Chromosomal Abnormalities Testing, HLA Typing for Stem Cell Transplantation
Which Trends Are Affecting The Preimplantation Genetic Testing Market Framework?
Leading firms within the pregnancy test kits market are prioritizing the creation of novel solutions, including saliva-based pregnancy tests, to boost user ease, facilitate non-invasive assessment, and sharpen the precision of early detection. Such a test involves a diagnostic kit capable of identifying pregnancy through the analysis of a woman’s saliva for human chorionic gonadotropin (hCG), the hormone generated in early pregnancy, thereby presenting a non-invasive and practical substitute for conventional urine tests. As an illustration, in June 2023, Salignostics Ltd., an Israel-based biotechnology enterprise, introduced Salistick, delivering a user-friendly, non-invasive solution for saliva-based pregnancy testing. This product accurately identifies the ß-hCG hormone with over 96% accuracy, effective as soon as one day after a missed period. Its primary benefits encompass eliminating the need for urine collection, allowing for sanitary and confidential testing anywhere without requiring bathroom facilities, and utilizing a straightforward foam stick to display results within 5-15 minutes. Additional advantages include heightened user comfort, the convenience of sharing results with partners, and dependable performance comparable to conventional tests, all while catering to global at-home diagnostic needs.
Who Are The Major Companies Operating In The Preimplantation Genetic Testing Market?
Major companies operating in the preimplantation genetic testing market are Thermo Fisher Scientific, Abbott Laboratories, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Illumina Inc., Revvity Health Science Inc., CooperSurgical Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, Takara Bio Inc., MedGenome Labs Ltd., Genea Limited, Ovation Fertility, Juno Genetics Ltd, Invicta Genetics, Progenesis, Bioarray SL, PacGenomics, Reproductive Genetic Innovations LLC, SEQUENCE46 LLC
Access The Complete Preimplantation Genetic Testing Market Report:
What Is The Largest Regional Market In The Preimplantation Genetic Testing Market?
North America was the largest region in the preimplantation genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the preimplantation genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Preimplantation Genetic Testing Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=20596&type=smp
Browse Through More Reports Similar to the Global Preimplantation Genetic Testing Market 2026, By The Business Research Company
Pediatric And Neonatal Testing Kit Global Market Report 2026
Ovulation Testing Kits Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/ovulation-testing-kits-global-market-report
Dna Test Kits Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/dna-test-kits-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model